Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer

Published:2016-08 Issue:1 Volume:379 Page:39-48
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Kim Ji Young,Cho Youngkwan,Oh Eunhye,Lee Nahyun,An Hyunsook,Sung Daeil,Cho Tae-Min,Seo Jae Hong

Funder

Korea Health Industry Development Institute

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference49 articles.

1. HER2 as a prognostic factor in breast cancer;Menard;Oncology,2001

2. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

3. Relationship of epidermal growth factor receptor expression to ErbB-2 signaling activity and prognosis in breast cancer patients;DiGiovanna;J. Clin. Oncol,2005

4. The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation;Holbro;Proc. Natl. Acad. Sci. U.S.A.,2003

5. Management of breast cancer with targeted agents: importance of heterogeneity. [Corrected];Di Cosimo;Nat. Rev. Clin. Oncol,2010

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing nanomaterials for copper-induced cell death;Biomaterials;2025-02

2. Disulfiram/copper complex improves the effectiveness of the WEE1 inhibitor Adavosertib in p53 deficient non-small cell lung cancer via ferroptosis;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-12

3. Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives;Journal of Hematology & Oncology;2024-08-16

4. The pathogenic role of retinoid nuclear receptor signaling in cancer and metabolic syndromes;Journal of Experimental Medicine;2024-08-12

5. A fibroblast activation protein α-activatable nanoagent co-delivering diethyldithiocarbamate and copper for tumor therapy and imaging;Acta Biomaterialia;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3